Georg A. Bjarnason

272 papers receiving 13.6k citations

Georg A. Bjarnason's Hit Papers

Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma 2021 · 183 citations
1830+5+11Years since publication50010001.5k

Peers

Georg A. Bjarnason
Comparison fields: 5 of 143
  • Cancer Research 4.5k
  • Pulmonary and Respiratory Medicine 8.0k
  • Endocrine and Autonomic Systems 1.5k
  • Oncology 4.5k
  • Aging 207
Replace David I. Quinn with:
David I. Quinn United States
Masayuki Takeda Japan
Sylvie Giacchetti France
Serge Adnot France
Antonino Belfiore Italy
Steven H. Lin United States
Javid J. Moslehi United States
Marcus Schmidt Germany
Shinzaburo Noguchi Japan
Thomas Fleming Germany
Georg A. Bjarnason relative to David I. Quinn United States David I. Quinn's profile →
Citations per field
00.5×11.6×
David I. Quinn · 1×
Citations per year

Countries citing papers authored by Georg A. Bjarnason

Since Specialization
Citations

This map shows the geographic impact of Georg A. Bjarnason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg A. Bjarnason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg A. Bjarnason more than expected).

Fields of papers citing papers by Georg A. Bjarnason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg A. Bjarnason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg A. Bjarnason. The network helps show where Georg A. Bjarnason may publish in the future.

Co-authors

The 25 scholars most cited alongside Georg A. Bjarnason, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Georg A. Bjarnason Line = papers co-authored together Georg A. Bjarnason links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 279 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Hit paper breakdown →
20091711
2
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
Hit paper breakdown →
20091383
3
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
Hit paper breakdown →
2013730
4 2009455
5 2001322
6 2014311
7 2013294
8 2015288
9 2009184
10
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma
Hit paper breakdown →
2021183
11 2013182
12 2006178
13 2011171
14
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial
Hit paper breakdown →
2021170
15 2013170
16 2021160
17 1999152
18 2014147
19 2013140
20 2011139

About Georg A. Bjarnason

Georg A. Bjarnason is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Economics and Econometrics, having authored 279 papers that have together received 13.8k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (188 papers), Cancer Genomics and Diagnostics (90 papers), Renal and related cancers (89 papers), Economic and Financial Impacts of Cancer (39 papers), Pancreatic and Hepatic Oncology Research (27 papers), Circadian rhythm and melatonin (23 papers), Cancer Immunotherapy and Biomarkers (22 papers) and Cancer Treatment and Pharmacology (19 papers). The work is most often cited by research in Cancer Research (4.5k citations), Pulmonary and Respiratory Medicine (8.0k citations), Endocrine and Autonomic Systems (1.5k citations), Oncology (4.5k citations) and Aging (207 citations). Georg A. Bjarnason has collaborated with scholars based in Canada, United States and Denmark. Frequent co-authors include Christina R. Lee, Robert S. Kerbel, William Cruz‐Muñoz, John M.L. Ebos, James G. Christensen, Richard C. Jordan, Frede Donskov, Toni K. Choueiri, Brian I. Rini and Lori Wood. Their work appears in journals such as Journal of Clinical Oncology, Clinical Genitourinary Cancer, Annals of Oncology, European Urology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact